Apex Frozen Foods Limited Overview
Apex Frozen Foods is a mid-sized, promoter-controlled Indian processor and exporter of farmed shrimp, headquartered in Kakinada on Andhra Pradesh's Godavari delta coast — the epicentre of India's Litopenaeus vannamei aquaculture. The company is vertically integrated from specific-pathogen-free (SPF) seed production in three owned hatcheries (1.2–1.4 billion seed capacity) through pre-processing and processing in two plants totalling 34,240 MTPA, with in-house cold storage of about 3,500 MT and owned reefer trucks. Effectively all finished output is exported, principally to the United States and European Union, sold B2B to food companies, retail chains, club stores, restaurants and distributors. Strategically, Apex is pivoting from commodity ready-to-cook (RTC) shrimp toward higher-margin ready-to-eat (RTE) cooked products and from US dependence toward the EU, UK and new markets. With revenue of Rs 931 cr in FY2026, a near-zero debt balance sheet and roughly 30% plant utilisation, its investment case is fundamentally one of operating leverage on trade-policy normalisation.
What the company does
Apex Frozen Foods processes and exports frozen shrimp. According to the business overview drawn from its FY2024 annual report (as summarised on Screener), the company is engaged in processing and preserving fish, crustaceans and molluscs, dealing primarily in processed frozen shrimp on a B2B basis; its distributors supply HORECA (hotels, restaurants, cafés) and departmental stores in the USA, EU and China, and the company also sells shrimp seed to farmers. Its Q1 FY27 investor presentation describes Apex as one of India's leading exporters of processed shrimp, with well-integrated operations spanning hatchery and processing/export, serving food companies, retail chains, restaurants, club stores and distributors.
Value chain position
| Stage | Activity | Ownership model |
|---|---|---|
| 1. Shrimp seed (hatchery) | Production of SPF vannamei post-larvae | In-house (three hatcheries, Andhra Pradesh) |
| 2. Shrimp farming | Grow-out in bio-secured ponds | Outsourced — raw shrimp is procured from third-party farmers within 20–200 km of the plants |
| 3. Pre-processing and processing | Sizing/grading, deheading (headless shell-on), peeling, cooking, value addition | In-house |
| 4. Logistics | Cold storage (~3,500 MT), owned refrigerated trucks, shipment as RTC or RTE | In-house to port; ocean freight via third-party carriers |
The company's own value-chain schematic (Q1 FY27 presentation) identifies four stages:
Apex therefore sits in the mid-stream "processor-exporter" position: it is backward-integrated into seed (a quality and farmer-relationship lever) but not into farming or feed. On the Q1 FY27 call, management explicitly confirmed the company has no exposure to feed manufacturing.
Business and revenue model
| Revenue type | Description | Share of revenue |
|---|---|---|
| Product sales — processed frozen shrimp (RTC and RTE) | Export sales priced per kg (USD/EUR), FOB/CFR or delivered terms depending on customer; US pricing embeds anti-dumping and countervailing duties | Substantially all; exact split not separately disclosed |
| Export incentives | Duty drawback, RoDTEP and similar benefits recognised within net revenue | Rs 49.3 cr in FY2026 (5.3% of net revenue); Rs 45.4 cr in FY2025; Rs 12.8 cr in Q1 FY27 |
| Shrimp seed sales | Sale of SPF post-larvae to farmers | Not separately disclosed; immaterial (no separate segment) |
| Service / subscription / licensing | — | 0% |
The model is pure product manufacturing and export: no subscription, licensing or service revenue. Revenue is a function of volume (metric tonnes shipped), product mix (RTC vs RTE; count sizes; species), USD/EUR price per kg, and the INR exchange rate.
Customer types and end-markets
Customers are importers, seafood brand owners, retail chains, club stores, restaurant suppliers and distributors. Historically, ICRA's 2017 rationale named Ocean World Ventures LLC and Chicken of the Sea Frozen Foods among major FY2016 clients; current customer names are not disclosed. End-consumption is retail (frozen aisle, cooked shrimp rings) and foodservice. Geographically, the end-markets are the USA, EU and UK, with "China & Others" a small residual; Japan business was re-initiated in FY2027 after more than a decade, and Russia and Australia are in development (Q1 FY27 call).
Independent characterisation
Apex is a commodity-exposed, cyclical exporter with three structural features that distinguish it from many Indian peers. First, it carries substantial unused capacity (roughly 30% utilisation in FY2026 on 10,286 MT shipped vs 34,240 MTPA), which makes earnings highly geared to volume recovery but also signals that the 2020 capacity build was ahead of demand. Second, it has an unusually clean balance sheet after FY2026 deleveraging (total borrowings Rs 5.7 cr, cash Rs 18.5 cr at 31 March 2026). Third, it has achieved a genuine geographic pivot: the EU rose from 26% of volume in FY2024 to 47% in FY2026, making non-US markets the majority (52%) for the first time in its history. The principal weaknesses are customer and geographic concentration, dependence on trade-policy outcomes (US tariffs, ADD/CVD, EU testing regimes), raw-material (farm-gate) price volatility, and thin through-cycle returns (Screener 3-year average ROE of about 4%).
Strategy
Stated strategic themes (paraphrased from FY2026–FY2027 investor communications)
-
Move up the value chain — increase the share of RTE and value-added products, which carry higher realisations and at least USD 0.50/kg higher margin than RTC.
-
Geographic diversification — reduce dependence on the US; build the EU, UK and new markets (Japan, Russia, Australia) to create a more resilient export portfolio.
-
Capacity utilisation — sweat the existing 34,240 MTPA asset base rather than add capacity; internal restructuring and cost measures implemented from mid-FY2026.
-
Lean balance sheet — disciplined working capital and minimal debt.
-
Leverage trade agreements — position for the India–UK agreement (effective 15 July 2026) and the India–EU FTA (expected implementation around end-2026/early 2027), contingent on removal of non-tariff barriers.
Initiatives announced in the last 24 months
| Initiative | Timing | Detail / status |
|---|---|---|
| EU approval for Unit 2 (G. Ragampeta) | Completed FY2025 | Enabled EU volume growth of 19% in FY2026 |
| EU-led diversification | FY2026 | EU share of volume rose to 47%; non-US 52% |
| Customer co-developed RTE products | FY2026–FY2027 | Commercialised; 3–4% of FY27 volume expected, at least 500 MT p.a. thereafter |
| Japan market re-entry | Initiated Q1–Q2 FY27 | First business in more than a decade |
| Russia market entry | Expected end-Q2 or Q3 FY27 | Regulatory investments made |
| Australia market entry | Pending customer audits | Discussion stage |
| Cost-efficiency programme | From mid-FY2026 | Specific savings targets not disclosed |
| Deleveraging | FY2025–FY2026 | Borrowings cut to Rs 5.7 cr |
| Investor outreach | 2025–2026 | Stellar IR engaged; regular calls; non-deal roadshow Sept 2026 |
No ESG or sustainability targets with quantified commitments were identified.
Medium-term guidance and targets
| Item | Guidance | Source / caveat |
|---|---|---|
| FY2027 shrimp volume | About 12,000 MT (≈17% growth on FY2026) | Management, Q1 FY27 call (reaffirmed). Some aggregators cite 14,000 MT / ~30% growth from the Q4 FY26 call; management explicitly corrected this to ~12,000 MT on 18 Aug 2026 |
| Next volume milestone | 14,000–15,000 MT (FY2028–FY2029 horizon; "premature" to commit) | Q1 FY27 call |
| RTE share of volume FY2027 | At least 18–20% (vs 16% in Q1 FY27) | Q1 FY27 call; Geojit |
| Capacity utilisation | Consistently 35–40% through FY2027 | Q1 FY27 call |
| Margins | Broadly stable around Q1 levels, subject to farm-gate and freight increases | Q1 FY27 call |
| Revenue | Approx. Rs 1,200 cr+ over two years | — |
| Order book | Covered to mid-Q3 FY27 | Q1 FY27 call |
| Capex / fundraising | None planned | Q1 FY27 and Q4 FY26 call summaries |
Products & Services
All products sit within the single "Shrimp Processing" segment. The company does not sell consumer brands publicly; products are supplied largely under customers' private labels.
Base and peeled products (Ready-to-Cook, raw frozen)
| Product | Description / specification | Target customer | Pricing model |
|---|---|---|---|
| Head-On shrimp | Whole raw shrimp, graded by count | Importers, Asian/European wholesale | Per kg, contract |
| Headless Shell-On (HLSO) | Head removed, shell intact; graded by count | US/EU importers, foodservice | Per kg, contract |
| Easy Peel | Shell slit and deveined for easy peeling, raw | Retail and foodservice | Per kg, contract |
| Peeled, Un-deveined (PUD) | Shell removed, vein intact | Processors, foodservice | Per kg, contract |
| Peeled and Deveined (PD) | Shell and vein removed, tail-off | Retail, foodservice | Per kg, contract |
| Peeled, Un-deveined, Tail-on (PUD-TO) | Tail fan retained | Foodservice | Per kg, contract |
| Peeled, Deveined, Tail-on (PDTO) | Shell and vein removed, tail retained | Retail, restaurant chains | Per kg, contract |
| Peeled, Deveined, Tail-off | As above, tail removed | Retail, further processors | Per kg, contract |
Specialty products (value-added RTC)
| Product | Description | Target customer |
|---|---|---|
| Butterfly shrimp | Split and flattened, typically tail-on | Foodservice, retail |
| Skewered shrimp | Raw shrimp on skewers for grilling | Retail, club stores |
| Seasoned shrimp | Marinated/seasoned raw shrimp | Retail |
| Dusted and breaded shrimp | Coated shrimp | Foodservice, retail |
| Par-fried shrimp | Partially fried coated shrimp | Foodservice |
Ready-to-Eat (RTE) products
| Product | Description | Target customer |
|---|---|---|
| Cooked Peeled & Deveined Tail-on (CPDTO) | Fully cooked, peeled, deveined, tail-on | US/EU retail and club stores |
| Cooked in Shell | Cooked whole or HLSO | EU retail |
| Shrimp Rings | Cooked shrimp arranged with cocktail sauce tray format | US retail (seasonal/party demand) |
| Customer-proprietary RTE products | Products co-developed with specific customers; commercialised and shipping as of Aug 2026; expected at 3–4% of FY27 volume (about 300–400 MT), rising to at least 500 MT annually | Named customers (undisclosed) |
Shrimp seed
| Product | Description | Capacity | Customer |
|---|---|---|---|
| SPF L. vannamei seed (post-larvae) | Specific-pathogen-free seed from three owned hatcheries | 1.2–1.4 billion seed p.a. | Shrimp farmers in Andhra Pradesh (also secures raw-material supply relationships) |
Species
Products are predominantly Pacific white shrimp (L. vannamei), India's dominant farmed species. Black tiger (P. monodon) has historically been part of Indian processors' offerings; the company's current species mix is not separately disclosed.
Launch chronology
| Capability | Year introduced |
|---|---|
| RTC raw frozen (base and peeled) | Since inception (predecessor firm) |
| Value-added pre-processing unit | 2,017 |
| RTE line 1 (5,000 MT) | Around 2020–21 at G. Ragampeta (exact date not disclosed) |
| RTE line 2 (5,000 MT) | End-May 2023 |
| Customer-proprietary RTE products | FY2026–FY2027 |
Financial Narrative
All figures in Rs crore unless stated; fiscal years ending 31 March. Source: Screener.in standardised audited statements unless stated otherwise; company investor presentations used where noted.
Income statement
Notes: Gross profit row from Sharpely's standardised statements (methodology differs from company); EBIT derived as PBT + finance cost. FY2026 DPS Rs 2.50 and FY2025 DPS Rs 2.00 confirmed by company filings; FY2022–FY2024 DPS derived from Screener payout ratios (19%, 22%, 43%) × EPS. Diluted EPS equals basic (no dilutive instruments disclosed).
Margins and growth
Revenue CAGR: FY2022–FY2026 (4 years) 0.1%; FY2021–FY2026 (5 years) 2.6% (FY2021 revenue Rs 818 cr); Screener's 10-year sales CAGR is 4%.
Balance sheet
Sources: FY2024–FY2026 from company presentations (Q4 FY26/Q1 FY27; total borrowings Rs 1,068 Mn, Rs 726 Mn and Rs 57 Mn; ST/LT split Rs 995/74 Mn, Rs 671/55 Mn, Rs 40/17 Mn). FY2022–FY2023 debt totals from Screener; short-term debt from StockAnalysis; long-term component derived as total minus short-term. Inventories and receivables FY2022–FY2023 from StockAnalysis. Goodwill/intangibles: none reported.
Cash flow
Sources: Screener cash-flow statements; company-reported FY2025 and FY2026 CFO Rs 543 Mn and Rs 958 Mn, investing outflows Rs 59 Mn and Rs 17 Mn, financing outflows Rs 492 Mn and Rs 778 Mn (Q1 FY27 presentation). Capex derived as CFO minus Screener FCF. Dividends paid derived as prior-year DPS × 3.125 cr shares (paid in the following fiscal year after AGM approval). No buybacks have been authorised.
Ratios
Notes: ROE/ROA computed on averages (FY2021 equity Rs 440 cr, total assets Rs 657 cr). ROCE from Screener; company reported FY2026 RoCE of 10.8% and ROE of 7.4% (Q4 FY26 presentation). FY2022–FY2023 current ratio approximate (derived from StockAnalysis current assets of Rs 412 cr and Rs 334 cr against estimated current liabilities); FY2024–FY2026 from company data. Net debt/EBITDA uses Screener operating profit. Working-capital days from Screener.
Quarterly trajectory (most recent five quarters)
Sources: company filings and presentations; Q2 FY26 and Q3 FY26 volumes derived as FY2026 total (10,286 MT) less disclosed quarters is not uniquely separable — Q2 and Q3 volume figures shown are derived estimates splitting the residual 5,359 MT using reported revenue proportions and should be treated as indicative only. Q2 FY26 EBITDA derived from Screener operating profit (Rs 11 cr) plus portion of export benefits — indicative; Q3 FY26 EBITDA Rs 13.40 cr per company release reported by Fyers. Q2 FY26 PAT includes an exceptional item relating to an IEIS licence from earlier years.
Commentary on trends, inflections and drivers
Revenue. The five-year record shows no structural growth: revenue oscillated between Rs 804 cr and Rs 1,070 cr. FY2023's peak reflected post-COVID restocking and elevated USD prices; FY2024's 25% collapse coincided with a global shrimp price slump (Ecuadorian oversupply), US retailer destocking and Apex's own loss of US volume. FY2025 was flat. FY2026's 14% growth came with essentially flat volume (10,286 MT vs 10,534 MT), meaning growth was price- and currency-driven: firmer global shrimp prices, a weaker rupee, a richer EU/RTE mix and higher export incentives.
Margins. The inflection is the most important development in the series. Company-reported EBITDA margin moved from 3.6% (FY2025) to 7.7% (FY2026) and 12.7% in Q1 FY27 — the highest quarterly level in at least five years and above the 10–11% pre-COVID range noted by Geojit. Drivers per management: realisation per kg up 15% YoY to about Rs 930 in Q1 FY27; stable farm-gate (raw shrimp) prices; cost-efficiency measures; and RTE mix. Countervailing pressures flagged for the rest of FY27: farm-gate prices up roughly 6–7% in the four weeks before mid-August 2026, and ocean freight costs more than doubled versus Q4 FY26 owing to war-related shipping disruption.
Balance sheet. FY2026 marked a decisive deleveraging: total borrowings fell from Rs 106.8 cr (March 2024) to Rs 5.7 cr (March 2026), driven by working-capital release (inventory down Rs 21 cr, receivables down Rs 18.5 cr in FY2026) and strong operating cash flow (Rs 95.8 cr). Net debt turned negative. Finance costs fell from Rs 8.8 cr to Rs 4.5 cr and were just Rs 0.3 cr in Q1 FY27.
Cash conversion. The business is structurally working-capital heavy (cash conversion cycle 118–167 days), because shrimp must be bought from farmers for cash at harvest and inventoried for shipment scheduling. Operating cash flow is therefore volatile and counter-cyclical to growth: FY2023 (revenue down in H2) produced Rs 121 cr of OCF; FY2024 only Rs 11 cr.
Returns. Through-cycle returns have been mediocre: ROCE fell from 40% in FY2018 to 2% in FY2025, as the Rs 165 cr G. Ragampeta plant (FY2020) added fixed costs and depreciation without commensurate volume. FY2026 recovered to about 10%.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Shrimp Processing segment revenue (INR Cr) | 804.1 | 813.6 | 931.1 |
YoY growth (%) | -24.8 | 1.2 | 14.4 |
Segment pre-tax income (INR Cr) | 19.6 | 5.6 | 53.0 |
Pre-tax margin (%) | 2.4 | 0.7 | 5.7 |
Contribution to total revenue (%) | 100 | 100 | 100 |
Operating Metrics (MT) and Revenue by Segment (%)
| KPI | FY2025 | FY2026 | Q1 FY26 | Q1 FY27 | Source |
|---|---|---|---|---|---|
Shrimp sales volume (MT) | 10,534 | 10,286 | 3,015 | 2,624 | Q4 FY26 and Q1 FY27 presentations/calls |
RTE share of volume (%) | — | 12 (Geojit) / ~15 (management, for FY26) | 15 | 16 | Q1 FY27 call; Geojit note (6 Oct 2026) |
Average realisation (Rs/kg) | — | approx. 905 (derived: revenue ÷ volume) | approx. 812 | approx. 930 | Q1 FY27 call; derived |
RTE realisation (USD/kg) | — | — | 11.18–11.20 | 12.05 | Q1 FY27 call |
Capacity utilisation (%) | approx. 31 (derived) | approx. 30 (derived) | 39 | 38 | Q1 FY27 call; derived on 34,240 MTPA |
“—” = not publicly disclosed.
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 926 | 1,070 | 804 | 814 | 931 |
Gross profit — aggregator basis (INR Cr) | 211 | 225 | 227 | 209 | 327 |
Operating profit / EBITDA excl. other income (INR Cr) | 86 | 83 | 40 | 25 | 56 |
Other income (INR Cr) | 6 | 2 | 3 | 5 | 17 |
Finance cost (INR Cr) | 17 | 15 | 9 | 9 | 4 |
Depreciation (INR Cr) | 19 | 19 | 15 | 15 | 15 |
Operating income / EBIT (INR Cr) | 73 | 66 | 29 | 15 | 57 |
Pre-tax income (INR Cr) | 56 | 51 | 20 | 6 | 53 |
Effective tax rate (%) | 27 | 29 | 25 | 31 | 27 |
Net income (INR Cr) | 41 | 36 | 15 | 4 | 39 |
EPS basic and diluted (INR) | 13.14 | 11.48 | 4.67 | 1.24 | 12.43 |
Dividend per share (INR) | 2.5 | 2.5 | 2.0 | 2.0 | 2.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Margin Analysis (%) (FY2025–FY2026)
| Metric | FY2025 | FY2026 |
|---|---|---|
Net revenue incl. export benefits (INR Mn) | 8,136 | 9,311 |
Export benefits included (INR Mn) | 454 | 493 |
Other income (INR Mn) | 46 | 173 |
Raw material cost (INR Mn) | 5,882 | 5,886 |
Gross profit (INR Mn) | 2,299 | 3,599 |
Gross margin (%) | 28.1 | 37.9 |
Employee expenses (INR Mn) | 453 | 491 |
Other expenses (INR Mn) | 1,549 | 2,379 |
EBITDA (INR Mn) | 297 | 729 |
EBITDA margin (%) | 3.6 | 7.7 |
Depreciation (INR Mn) | 153 | 154 |
Finance cost (INR Mn) | 88 | 45 |
PBT (INR Mn) | 56 | 530 |
Tax (INR Mn) | 17 | 142 |
PAT (INR Mn) | 39 | 388 |
PAT margin (%) | 0.5 | 4.1 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin — aggregator basis (%) | 22.8 | 21.0 | 28.2 | 25.7 | 35.1 |
Operating (EBITDA excl. OI) margin (%) | 9.3 | 7.8 | 5.0 | 3.1 | 6.0 |
EBIT margin (%) | 7.9 | 6.2 | 3.6 | 1.8 | 6.1 |
Pre-tax margin (%) | 6.0 | 4.8 | 2.5 | 0.7 | 5.7 |
Net margin (%) | 4.4 | 3.4 | 1.8 | 0.5 | 4.2 |
Revenue growth YoY (%) | 13.2 | 15.6 | -24.9 | 1.2 | 14.4 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 678 | 614 | 633 | 613 | 593 |
Cash and equivalents (INR Cr) | 1.0 | 1.6 | 3.0 | 2.1 | 18.5 |
Short-term debt (INR Cr) | 137 | 86 | 99.5 | 67.1 | 4.0 |
Long-term debt incl. current portion (INR Cr) | 30 | 5 | 7.4 | 5.5 | 1.7 |
Total debt (INR Cr) | 167 | 91 | 106.8 | 72.6 | 5.7 |
Net debt (INR Cr) | 166 | 89 | 103.8 | 70.5 | -12.8 |
Shareholders' equity (INR Cr) | 468 | 490 | 497.1 | 494.5 | 528.0 |
Goodwill and intangibles (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Net block (INR Cr) | 236 | 242 | 254 | 243 | 239 |
Inventories (INR Cr) | 202.8 | 177.9 | 194.1 | 187.5 | 166.5 |
Trade receivables (INR Cr) | 132.0 | 112.1 | 106.9 | 127.0 | 108.5 |
Liquidity & Coverage Ratios and Financial Ratios (x)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Current assets (INR Cr) | 363.3 | 354.4 | 317.8 |
Current liabilities (INR Cr) | 120.6 | 104.5 | 53.3 |
Net working capital (INR Cr) | 242.7 | 249.9 | 264.5 |
Current ratio (x) | 3.01 | 3.39 | 5.96 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (INR Cr) | 36 | 121 | 11 | 54 | 96 |
Investing cash flow (INR Cr) | -10 | -22 | -8 | -6 | -2 |
Capex — derived (INR Cr) | 11 | 21 | 12 | 8 | 6 |
Free cash flow (INR Cr) | 25 | 100 | -1 | 46 | 90 |
Financing cash flow (INR Cr) | -27 | -99 | -2 | -49 | -78 |
Dividends paid — derived (INR Cr) | 6.3 | 7.8 | 7.8 | 6.3 | 6.3 |
Share buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on average equity (%) | 9.0 | 7.5 | 3.0 | 0.8 | 7.6 |
ROA on average assets (%) | 6.1 | 5.6 | 2.4 | 0.6 | 6.4 |
ROCE — ROIC proxy (%) | 12 | 11 | 5 | 2 | 10 |
Current ratio (x) | 2.5 | 3.4 | 3.0 | 3.4 | 6.0 |
Debt to equity (x) | 0.36 | 0.19 | 0.21 | 0.15 | 0.01 |
Net debt to EBITDA (x) | 1.93 | 1.07 | 2.60 | 2.82 | -0.23 |
Interest coverage EBIT/interest (x) | 4.3 | 4.4 | 3.2 | 1.7 | 14.3 |
Asset turnover (x) | 1.39 | 1.66 | 1.29 | 1.31 | 1.54 |
Debtor days | 52 | 38 | 49 | 57 | 43 |
Inventory days | 120 | 88 | 129 | 119 | 105 |
Payable days | 12 | 8 | 10 | 17 | 18 |
Cash conversion cycle (days) | 160 | 118 | 167 | 159 | 129 |
Income Statement and Margin Analysis (%) (Quarterly)
| Metric | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|
Revenue (INR Cr) | 258.2 | 238.3 | 264.0 | 167.8 | 256.5 |
Company EBITDA (INR Cr) | 18.4 | 13.0 | 13.4 | 16.9 | 33.0 |
EBITDA margin (%) | 7.1 | 5.5 | 5.1 | 9.8 | 12.7 |
PAT (INR Cr) | 9.10 | 11.87 | 10.09 | 7.79 | 21.67 |
EPS (INR) | 2.91 | 3.80 | 3.23 | 2.49 | 6.93 |
Shrimp volume (MT) | 3,015 | 2,700 | 2,659 | 1,912 | 2,624 |
Geographic Revenue
| Region | FY2024 | FY2026 | Source |
|---|---|---|---|
European Union (incl. UK where grouped) | 26 | 47 | Q4 FY26 presentation |
USA | — | 48 | FilingReader summary of Q4 FY26 presentation |
Others (China, Japan, other) | — | approx. 5 (residual) | Derived |
Non-US total | — | 52 | Q4 FY26 call summaries |
“—” = not publicly disclosed.
Revenue by Region (%)
| Region | Q1 FY26 | Q1 FY27 |
|---|---|---|
USA share of shrimp sales (%) | 54 | 70 |
EU and UK share (%) | 39 | 25 |
Others share (%) | 7 | 5 |
Capital Markets
| Measure | Value | Source |
|---|---|---|
Share price (19 Oct 2026, intraday) | Rs 331 | Screener |
52-week high / low | Rs 514 / Rs 227 | Screener |
1-year price CAGR | 49% | Screener |
3-year price CAGR | 16% | Screener |
5-year price CAGR | 4% | Screener |
Reaction to Q1 FY27 results (14 Aug 2026) | +16% intraday to ~Rs 426 | Angel One |
Market capitalisation | approx. Rs 1,033 cr | Screener |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
P/E (TTM) | 20.8x (Screener); 20.1x on TTM EPS Rs 16.45 | Price Rs 331 |
P/E (FY2026) | 26.6x | FY2026 EPS Rs 12.43 |
P/B | 1.96x | Book value Rs 169 per share |
Enterprise value | approx. Rs 1,020 cr | Market cap + debt Rs 5.7 cr − cash Rs 18.5 cr (Mar 2026 balances) |
EV/EBITDA (TTM, Screener operating profit Rs 68 cr) | approx. 15.0x | Derived |
EV/EBITDA (FY2026 company EBITDA Rs 72.9 cr) | approx. 14.0x | Derived |
EV/Sales (TTM revenue Rs 927 cr) | approx. 1.1x | Derived |
Dividend yield | 0.72–0.76% | Rs 2.50 DPS |
Analyst Ratings & Targets
| Broker | Date | Rating | Target price | Basis |
|---|---|---|---|---|
Geojit Investments | 6 Oct 2026 | BUY (maintained) | Rs 430 | 17x FY28E EPS (implied FY28E EPS ~Rs 25.3, derived) |
Per-Share Data and Returns & Leverage Ratios (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 2.5 | 2.5 | 2.0 | 2.0 | 2.5 |
Payout ratio (%) | 19 | 22 | 43 | 161 | 20 |
Credit Ratings
| Agency | Instrument | Rating | Outlook | Date |
|---|---|---|---|---|
CRISIL Ratings | Short-term bank facilities (Rs 161.44 cr) | CRISIL A2 (downgraded from A2+) | n/a (short-term) | 1 Aug 2025 |
CRISIL Ratings | Long-term rating | Previously CRISIL A-/Stable (2018–2022); no current long-term rating identified | — | — |
ICRA | Bank facilities | Withdrawn at company request | — | Mar 2022 |
Moody's / S&P / Fitch | — | Not rated | — | — |
Analyst Conclusions
Management guidance (as of 18 Aug 2026)
FY2027 volume of about 12,000 MT (implying roughly 9,400 MT across Q2–Q4 after 2,624 MT in Q1); RTE at least 18–20% of volume; utilisation 35–40%; margins broadly stable around Q1 levels absent further freight or farm-gate shocks; order book to mid-Q3 FY27; no capex or fundraising. Realisation in Q2 FY27 indicated at similar levels to Q1 (~Rs 900+/kg).
Consensus growth expectations
No multi-broker consensus. Geojit's Rs 430 target on 17x FY28E EPS implies FY2028 EPS of about Rs 25 (derived), i.e., roughly double FY2026's Rs 12.43, while Geojit has factored in some moderation from Q1 FY27 margins.
Bull case
-
Operating leverage on volume: a lift from 10,286 MT to 12,000 MT (FY27) and 14,000–15,000 MT (FY28–29) on fixed capacity, at Q1 FY27-type realisations (~Rs 930/kg), would push revenue toward Rs 1,100–1,400 cr with margin expansion from fixed-cost absorption.
-
Trade-policy tailwinds compounding: US tariff at 10% (vs 50% in late 2025), possible CVD cut from 5.77% with retroactive refunds, and India–EU FTA implementation could all land between Dec 2026 and mid-2027.
-
Balance sheet optionality: net cash and FCF of ~Rs 90 cr in FY2026 enable higher payouts or opportunistic market-share gains as leveraged peers (e.g., Coastal, CARE D) retrench.
Bear case
-
Q1 FY27 margin is a high-water mark: it combined peak realisations, INR weakness and stable farm-gate prices; farm-gate prices (+6–7%) and freight (>2x) are already rising.
-
Volume execution risk: Q1 FY27 volume fell 13% YoY; management has repeatedly guided to utilisation gains that have not materialised (e.g., ~50% target for FY27 cited in FY26 call summaries vs 35–40% now).
-
Structural mediocrity: five-year revenue CAGR ~3% and 3-year ROE ~4%; at ~20x TTM earnings and ~14x EV/EBITDA, the stock prices in sustained recovery for a commodity processor with high policy exposure and export incentives exceeding PAT in FY2026.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| Nov 2026 | Q2 FY27 results: volume recovery (EU spillover), freight impact on margins |
| ~Sept–Dec 2026 | US ADD final determination and CVD review outcome; any refund mechanics |
| Dec 2026 – Jan 2027 | India–EU FTA implementation; changes to EU border-testing frequency |
| FY2027 | RTE share reaching 18–20%; Russia/Australia/Japan shipments |
| Ongoing | Farm-gate price trend; INR/USD; ocean freight rates; labour availability |
| Ongoing | Any US tariff policy change; IEEPA tariff refund litigation |
| H1 2027 | CRISIL rating review (possible upgrade); dividend policy given net cash |
| May 2027 | FY2027 results vs ~12,000 MT guidance |
Analyst verdict
Apex Frozen Foods enters the second half of FY2027 in its strongest financial position since the 2017 IPO. FY2026 delivered a nine-fold profit increase on 14% revenue growth, debt has effectively been eliminated, and Q1 FY27 produced a 12.7% EBITDA margin — the best quarterly profitability in years — despite a 13% volume decline. The company has also demonstrated something rare among mid-sized Indian shrimp exporters: the ability to redirect nearly half its volume to Europe within two years when US access was impaired, and then swing back to the US when tariffs normalised.
Yet the core investment debate is unchanged from five years ago: can Apex convert idle capacity into sustained volume? The G. Ragampeta plant has run well below potential since 2020, revenue is no higher than in FY2022, and the recent earnings recovery is predominantly a price, currency and mix story rather than a volume story. Management's own FY2027 guidance (~12,000 MT, 35–40% utilisation) is modest, and Q1 shortfalls mean H2 delivery must accelerate. Meanwhile, the factors that inflated Q1 margins — benign farm-gate prices and favourable currency — are partially reversing, and freight has spiked.
At roughly Rs 331, the stock trades at about 20x trailing earnings and 14–15x EV/EBITDA, having given back about a third of its post-results high. That valuation is neither demanding nor cheap for a business with net cash, but also with commodity cyclicality, high trade-policy exposure and limited disclosure. The balance of evidence supports a constructive but conditional stance: the asymmetric upside lies in trade-policy outcomes (US CVD review, EU FTA) and RTE mix, which could lift utilisation toward 40–45% and normalise ROCE in the mid-teens. Investors should demand evidence of volume delivery in Q2–Q3 FY27 before underwriting a sustained re-rating; failure to approach ~12,000 MT would signal that FY2026–Q1 FY27 margins were cyclical rather than structural.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Tenure / term | Prior roles and experience | Age (approx.) |
|---|---|---|---|---|
Karuturi Satyanarayana Murthy (DIN 05107525) | Executive Chairman (Co-Promoter); previously Chairman & Managing Director | Re-appointed as Executive Chairman for five years, 1 Dec 2025 – 30 Nov 2030 | Over 30 years in the aqua industry; oversees daily management and strategy execution | Born 1955 (~71) |
Karuturi Subrahmanya Chowdary (DIN 03619259) | Managing Director and Chief Financial Officer (Co-Promoter) | Re-appointed as MD for five years, 1 Dec 2025 – 30 Nov 2030 | More than 24 years in the aqua sector; technical and managerial expertise; leads investor communication | Born 1979 (~47) |
Karuturi Neelima Devi (DIN 06765515) | Whole-Time Director (Co-Promoter) | Re-appointed WTD effective 1 Feb 2026; retired by rotation and re-appointed at 13th AGM | Over 13 years in the aqua industry | Not confirmed |
Durga Prasad | Senior Manager, Accounts | — | Represents finance function on earnings calls | — |
Company Secretary & Compliance Officer | Not identified in sources reviewed | — | — | — |
“—” = not publicly disclosed.
Board of Directors — B. Raghavulu Naidu
| Name | Role | Term / notes |
|---|---|---|
B. Raghavulu Naidu | Independent Director | Re-appointed effective 4 June 2026; enrolled with the Bar Council of India |
Govindareddy Krishnamoorthy | Independent Director | Re-appointed effective 22 June 2026; continuation required special resolution under SEBI rules for directors above 75 (as referenced in FY2025 Directors' Report) |
Deepthi Talluri (DIN 08726143) | Independent Director (woman director) | Second five-year term, 31 March 2025 – 30 March 2030 |
Board & Management Changes
| Date | Change |
|---|---|
6 Sept 2025 | Board approves re-appointments of Executive Chairman and MD (from 1 Dec 2025) and WTD (from 1 Feb 2026); appoints secretarial auditor |
1 Dec 2025 | K.S. Murthy's role re-designated/continued as Executive Chairman; K.S. Chowdary as MD |
4 and 22 June 2026 | Independent directors B. Raghavulu Naidu and G. Krishnamoorthy re-appointed |
Shareholding Trend
| Holder category | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
Promoters (%) | 72.62 | 72.62 | 72.62 | 72.62 | 72.62 |
FIIs (%) | 0.00 | 3.29 | 6.00 | 5.83 | 4.82 |
DIIs (%) | 0.05 | 0.44 | 0.66 | 0.61 | 0.61 |
Public (%) | 27.32 | 23.65 | 20.73 | 20.93 | 21.94 |
Number of shareholders | 42,155 | 40,895 | 39,165 | 39,978 | 39,529 |
Competitive Landscape
Key Competitors
| Company | Profile | FY2026 revenue | Relative positioning |
|---|---|---|---|
Avanti Feeds Ltd | India's largest shrimp feed maker (775,000 MT feed capacity) with a processing/export subsidiary (Avanti Frozen Foods, ~28,000 MT processing; Thai Union is a long-standing partner) | Consolidated revenue above Rs 6,000 cr; net profit Rs 657 cr (FY2026) | Far larger, integrated into feed; processing arm grew strongly (processed shrimp revenue +64% YoY in Q2 FY26) |
Coastal Corporation Ltd | Visakhapatnam-based processor-exporter; brands Coastal, Coastal Gold, Jewel, President | Rs 970.7 cr (FY2026, +54.5%) per company-filings aggregator | Similar scale to Apex; stressed — CARE downgraded facilities to CARE D on 6 Aug 2026 |
Kings Infra Ventures Ltd | Kerala-based seafood processor/exporter | — | Much smaller |
Zeal Aqua Ltd | Gujarat-based shrimp processor/exporter | — | Smaller |
The Waterbase Ltd | Shrimp feed and hatchery; limited processing | — | Adjacent (feed) |
Peer Comparison FY2026
| Metric | Apex Frozen Foods | Avanti Feeds (consolidated) | Coastal Corporation |
|---|---|---|---|
Revenue FY2026 (INR Cr) | 931 |
| 971 |
Revenue growth FY2026 (%) | 14.4 | approx. flat (consolidated, per DSIJ) | 54.5 |
EBITDA margin FY2026 (%) | 7.7 | — | approx. 5–9 by quarter (Q4 FY26 OPM 4.97%) |
Net profit FY2026 (INR Cr) | 38.8 | 657 | — |
Net debt / balance sheet | Net cash | Net cash (historically) | Stressed; CARE D (Aug 2026) |



